Call to arrange a consultation
+1 416 777 0888

Boehringer Ingelheim (Canada) Ltd et al. v Laboratoire Riva Inc.

2022
T-191-23
Pending
New PM(NOC) Regulations

Action under the new Patented Medicines (Notice of Compliance) Regulations regarding Patent No. 2,782,179 (linagliptin).

Counsel to: 
Laboratoire Riva Inc.
here.
Arrow down